Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • February 29th, 2024 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2024 Company Industry JurisdictionZentalis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
ZENTALIS PHARMACEUTICALS, INC. INDENTURE Dated as of, 20 TrusteeIndenture • February 29th, 2024 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2024 Company Industry JurisdictionIndenture dated as of , 20 between Zentalis Pharmaceuticals, Inc., a company incorporated under the laws of the state of Delaware (“Company”), and [] (“Trustee”).